{site_meta && site_meta.display_name} Logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

InvestorNewsBreaks – Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Advanced Cancer Drug Delivery Technologies

June 2, 2026Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in a BioMedWire editorial examining how biotechnology companies are increasingly focusing on advanced drug delivery technologies to enhance the effectiveness of existing cancer therapies. The article highlights growing industry interest in nanoparticle delivery systems, intravenous reformulations and precision pharmacokinetic approaches designed to improve bioavailability, systemic exposure, tolerability and dosing consistency.


BioMedNewsBreaks — Oncotelic Therapeutics, Inc. (OTCQB: OTLC) Featured in BioMedWire Editorial on Advanced Cancer Drug Delivery Technologies

June 2, 2026Oncotelic Therapeutics (OTCQB: OTLC) announced its inclusion in a BioMedWire editorial examining how biotechnology companies are increasingly focusing on advanced drug delivery technologies to enhance the effectiveness of existing cancer therapies. The article highlights growing industry interest in nanoparticle delivery systems, intravenous reformulations and precision pharmacokinetic approaches designed to improve bioavailability, systemic exposure, tolerability and dosing consistency.


BioMedNewsBreaks – Lantern Pharma (NASDAQ: LTRN) Reports Phase 2 HARMONIC Trial Data Supporting LP-300 in EGFR-Mutant Lung Cancer

June 2, 2026Lantern Pharma (NASDAQ: LTRN), an AI-driven precision oncology company, reported updated Phase 2 HARMONIC trial data showing that LP-300, in combination with carboplatin and pemetrexed, demonstrated a progression-free survival benefit that increased with treatment duration in patients with EGFR Exon 21 L858R-mutant non-small cell lung cancer who had progressed following TKI therapy. The emerging data showed a median progression-free survival of 8.


Rallying Chip Stocks Reignite AI Bubble Debate

June 2, 2026Companies making AI chips have registered a major rally in the prices of their shares, and this has added momentum to the growing debates about whether or not these surges are fueling an AI bubble that could burst anytime. How long will this demand continue?


FinTechs on Notice as Digital Fraud Ticks Upwards

June 2, 2026The rapid shift of financial services into digital spaces is creating new opportunities for cybercriminals, many of whom are increasingly relying on AI to outsmart security checks. From fabricated identities to altered documents, fraudsters are using advanced tools to bypass verification systems that many financial technology companies still struggle to secure.


Renewable Energy Could Ease Food Production

June 2, 2026The disruption of global oil supplies following the Strait of Hormuz closure has pushed energy costs higher across every sector, including food. Modern food systems consume up to 30% of global oil supplies, making the fossil fuel integral to the agricultural sector.


Industrial Demand is Reshaping the Silver Market

June 2, 2026Silver has traditionally been viewed alongside gold as a safe-haven asset, attracting investors during inflationary periods and economic uncertainty. Today, however, the market is increasingly being driven by industrial consumption rather than investment demand alone.


Sam Altman Says AI is Unlikely to Trigger ‘Jobs Apocalypse’

June 2, 2026OpenAI chief executive officer Sam Altman remarked recently that fears of AI triggering mass unemployment may have been overstated, noting that the technology hasn’t displaced office-based workers as quickly as he once expected. As the tech field undergoes even more disruption in the wake of quantum computing being advanced by enterprises like D-Wave Quantum Inc.


New Inhalable Agent Could Improve Treatment Outcomes in Lung Cancer

June 2, 2026A new viral-based vector that can be inhaled into the lungs could boost the anti-cancer response of the body in patients diagnosed with advanced lung cancer. This new treatment could also restore sensitivity to immune checkpoint inhibitors among patients that had become unresponsive.


Stellantis Wants to Unveil 29 EV Models by 2030

June 2, 2026Multinational vehicle manufacturer Stellantis has revealed plans to release 29 electric vehicle models by the end of the decade. The company behind some of the world’s largest automakers will go all in on electric vehicle development over the next 5 years to launch over two dozen EV models as part of a strategic plan designed to give Stellantis an edge in the growing electric vehicle industry.


AINewsBreaks – MAX Power Mining Corp. (CSE: MAXX) (OTC: MAXXF) (FRANKFURT: 89N) Featured in AINewsWire Editorial on AI-Driven Energy Demand and Natural Hydrogen

June 2, 2026This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX) (OTC: MAXXF) (FRANKFURT: 89N) announced its inclusion in an AINewsWire editorial examining how surging electricity demand from artificial intelligence infrastructure is accelerating interest in natural hydrogen as a potential large-scale energy solution.


InvestorNewsBreaks – BOXABL Launches Beta Housing Configurator to Support Phase 2 Growth Strategy

June 2, 2026BOXABL announced the launch of a beta online catalog and configurator on its developer webpage, marking a key milestone in the company’s Phase 2 growth strategy. The platform showcases a growing portfolio of residential products and reflects BOXABL’s transition from its initial Casita offering toward a broader housing system designed around standardized manufacturing technology.